GAMMA Investing LLC lifted its stake in Reinsurance Group of America, Incorporated (NYSE:RGA - Free Report) by 54,931.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 474,923 shares of the insurance provider's stock after buying an additional 474,060 shares during the period. GAMMA Investing LLC owned approximately 0.72% of Reinsurance Group of America worth $93,512,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of RGA. Barclays PLC increased its holdings in shares of Reinsurance Group of America by 5.5% in the third quarter. Barclays PLC now owns 102,790 shares of the insurance provider's stock worth $22,396,000 after buying an additional 5,398 shares during the period. KBC Group NV increased its holdings in shares of Reinsurance Group of America by 217.4% in the fourth quarter. KBC Group NV now owns 5,412 shares of the insurance provider's stock worth $1,156,000 after buying an additional 3,707 shares during the period. Perigon Wealth Management LLC increased its holdings in shares of Reinsurance Group of America by 14.2% in the fourth quarter. Perigon Wealth Management LLC now owns 1,383 shares of the insurance provider's stock worth $310,000 after buying an additional 172 shares during the period. Caprock Group LLC increased its holdings in shares of Reinsurance Group of America by 55.9% in the fourth quarter. Caprock Group LLC now owns 1,702 shares of the insurance provider's stock worth $364,000 after buying an additional 610 shares during the period. Finally, Spire Wealth Management increased its holdings in shares of Reinsurance Group of America by 39.0% in the fourth quarter. Spire Wealth Management now owns 203 shares of the insurance provider's stock worth $43,000 after buying an additional 57 shares during the period. Hedge funds and other institutional investors own 95.11% of the company's stock.
Analyst Upgrades and Downgrades
Several research analysts have recently commented on the company. JPMorgan Chase & Co. upgraded Reinsurance Group of America from a "neutral" rating to an "overweight" rating and lifted their price objective for the stock from $232.00 to $237.00 in a report on Wednesday, April 2nd. Raymond James reiterated a "market perform" rating on shares of Reinsurance Group of America in a report on Friday, May 23rd. Morgan Stanley set a $209.00 target price on Reinsurance Group of America and gave the stock an "equal weight" rating in a research note on Monday, May 19th. Keefe, Bruyette & Woods raised their target price on Reinsurance Group of America from $250.00 to $255.00 and gave the stock an "outperform" rating in a research note on Wednesday, May 7th. Finally, UBS Group reissued a "neutral" rating and issued a $216.00 target price (down from $250.00) on shares of Reinsurance Group of America in a research note on Wednesday, April 2nd. Four equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $228.85.
Read Our Latest Analysis on Reinsurance Group of America
Reinsurance Group of America Stock Up 0.9%
Reinsurance Group of America stock traded up $1.73 during trading hours on Thursday, hitting $201.35. 424,781 shares of the stock traded hands, compared to its average volume of 412,300. The firm's 50-day moving average price is $193.25 and its two-hundred day moving average price is $204.94. The company has a current ratio of 0.15, a quick ratio of 0.17 and a debt-to-equity ratio of 0.46. The company has a market cap of $13.31 billion, a PE ratio of 18.75 and a beta of 0.63. Reinsurance Group of America, Incorporated has a one year low of $159.25 and a one year high of $233.81.
Reinsurance Group of America (NYSE:RGA - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The insurance provider reported $5.66 earnings per share for the quarter, beating the consensus estimate of $5.33 by $0.33. The business had revenue of $5.26 billion for the quarter, compared to analysts' expectations of $5.74 billion. Reinsurance Group of America had a return on equity of 14.55% and a net margin of 3.24%. The business's revenue was down 17.0% on a year-over-year basis. During the same period in the previous year, the firm posted $6.02 EPS. On average, research analysts forecast that Reinsurance Group of America, Incorporated will post 22.9 EPS for the current year.
Reinsurance Group of America Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th were given a dividend of $0.89 per share. The ex-dividend date was Tuesday, May 13th. This represents a $3.56 annualized dividend and a yield of 1.77%. Reinsurance Group of America's payout ratio is 30.04%.
About Reinsurance Group of America
(
Free Report)
Reinsurance Group of America, Incorporated engages in reinsurance business. The company offers individual and group life and health insurance products, such as term life, credit life, universal life, whole life, group life and health, joint and last survivor insurance, critical illness, disability, and longevity products; asset-intensive and financial reinsurance products; and other capital motivated solutions.
See Also

Before you consider Reinsurance Group of America, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reinsurance Group of America wasn't on the list.
While Reinsurance Group of America currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.